Skip to main content

Table 3 Univariate and multivariate analysis of prognostics factors for overall survival in NBNC-HCC patients after curative resection

From: Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection

Variable

Comparison

Univariate

Multivariate

HR (95%CI)

p value

HR (95%CI)

p value

Age (years)

> 60 vs ≦ 60

1.971 (1.161–3.348)

0.012

  

Sex

Male vs. Female

0.996 (0.569–1.641)

0.899

  

DM

Yes vs. no

1.439 (0.894–2.315)

0.134

  

Hypertension

Yes vs. no

1.099 (0.655–1.842)

0.721

  

Alcoholic history

Yes vs. no

1.452 (0.785–2.687)

0.235

  

AFP (ng/mL)

> 200 vs. ≦ 200

2.303 (1.248–4.251)

0.008

2.729 (1.452–5.130)

0.002

Platelet (\({10}^{9}\)/L)

≦ 150 vs. > 150

1.031 (0.596–1.785)

0.912

  

Albumin(g/dL)

≦ 3 vs. > 3

2.369 (1.338–4.193)

0.003

  

Liver cirrhosis

Yes vs. no

1.537 (0.919–2.568)

0.101

  

Child–Pugh grade

B vs. A

1.545 (0.621–3.888)

0.346

  

ALBI grade

II/III vs. I

3.395 (1.420–4.038)

0.001

2.432 (1.392–4.250)

0.002

Tumor size (cm)

> 5 vs. ≦ 5

1.481 (0.924–2.375)

0.103

  

Tumor no

Multiple vs. Single

2.029 (0.636–6.475)

0.232

  

BCLC stage

B vs. 0/A

1.456 (0.910–2.329)

0.117

  

Liver fat content (%)

> 30 vs. ≦ 30

0.802 (0.376–1.711)

0.569

  

Microvascular invasion

Yes vs. no

0.667 (0.389–1.145)

0.142

  

pTNM stages

III vs. I + II

5.669 (2.543–12.640)

< 0.001

4.902 (2.036–11.803)

 < 0.001

Histology stages

Poor vs. well/moderate

2.085 (0.832–5.230)

0.117

  
  1. DM diabetes mellitus, AST aspartate aminotransferase, ALBI albumin–bilirubin, BCLC Barcelona Clinic Liver Cancer, pTNM pathological tumor-node-metastasis